Permethrin
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Scabies
Conditions
Scabies
Trial Timeline
Sep 1, 2015 → Aug 1, 2016
NCT ID
NCT02572986About Permethrin
Permethrin is a phase 3 stage product being developed by Dr. Reddy's Laboratories for Scabies. The current trial status is completed. This product is registered under clinical trial identifier NCT02572986. Target conditions include Scabies.
What happened to similar drugs?
1 of 2 similar drugs in Scabies were approved
Approved (1) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02572986 | Phase 3 | Completed |
Competing Products
3 competing products in Scabies
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Spinosad Topical | Inotiv | Approved | 40 |
| Permethrin Foam 4% + Permethrin Foam 5% + Vehicle Foam | Viatris | Phase 2 | 32 |
| Permethrin Cream, 5% + Elimite | Mayne Pharma Group | Phase 3 | 30 |